Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis
Completed
Grünenthal GmbH
Phase 3
2008-09-01
The purpose of this study is to determine the effectiveness and safety of tapentadol
immediate release (IR) as compared with placebo and oxycodone IR in patients with acute pain
caused by vertebral compression fractures (VCF) associated with assumed osteoporosis for whom
treatment with oral opioid analgesics is appropriate.
Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis
Completed
Ortho-McNeil Janssen Scientific Affairs, LLC
Phase 3
2008-09-01
The purpose of this study is to determine the effectiveness and safety of tapentadol
immediate release (IR) as compared with placebo and oxycodone IR in patients with acute pain
caused by vertebral compression fractures (VCF) associated with assumed osteoporosis for whom
treatment with oral opioid analgesics is appropriate.
Safety and Efficacy of Tapentadol Immediate Release (IR) and Oxycodone IR for Treatment of Acute Post-op Pain Following Elective Arthroscopic (Surgery Using a Thin Flexible Scope) Shoulder Surgery
Completed
Grünenthal GmbH
Phase 3
2008-12-01
The purpose of this study is to evaluate how tapentadol immediate release (IR) and oxycodone
IR treat moderate to severe post-operative pain after elective arthroscopic shoulder surgery.
Safety and Efficacy of Tapentadol Immediate Release (IR) and Oxycodone IR for Treatment of Acute Post-op Pain Following Elective Arthroscopic (Surgery Using a Thin Flexible Scope) Shoulder Surgery
Completed
Ortho-McNeil Janssen Scientific Affairs, LLC
Phase 3
2008-12-01
The purpose of this study is to evaluate how tapentadol immediate release (IR) and oxycodone
IR treat moderate to severe post-operative pain after elective arthroscopic shoulder surgery.
Caffeine/Propranolol Intervention for Acute Migraine
Completed
Stanford University
Phase 2
2007-01-01
This is a research study to assess the safety of caffeine/propranolol at different dose
levels. We want to find out what effects, good and/or bad, it has on patients and their
migraines.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
